Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A National Representative, Cross-Sectional Study by the Hellenic Academy of NeuroImmunology (HEL.A.NI.) on COVID-19 and Multiple Sclerosis: Overall Impact and Willingness Toward Vaccination.
Boziki M, Styliadis C, Bakirtzis C, Grigoriadou E, Sintila AS, Nikolaidis I, Vrienniou A, Geys L, Pelidou SH, Probert L, Papazisis G, Bamidis P, Grigoriadis N. Boziki M, et al. Among authors: grigoriadou e. Front Neurol. 2021 Nov 25;12:757038. doi: 10.3389/fneur.2021.757038. eCollection 2021. Front Neurol. 2021. PMID: 34899577 Free PMC article.
Long-term effects of prolonged-release fampridine in cognitive function, fatigue, mood and quality of life of MS patients: The IGNITE study.
Bakirtzis C, Konstantinopoulou E, Langdon DW, Grigoriadou E, Minti F, Nikolaidis I, Boziki MK, Tatsi T, Ioannidis P, Karapanayiotides T, Afrantou T, Hadjigeorgiou G, Grigoriadis N. Bakirtzis C, et al. Among authors: grigoriadou e. J Neurol Sci. 2018 Dec 15;395:106-112. doi: 10.1016/j.jns.2018.10.004. Epub 2018 Oct 4. J Neurol Sci. 2018. PMID: 30308444
Induction of apoptosis in CD4(+) T-cells is linked with optimal treatment response in patients with relapsing-remitting multiple sclerosis treated with Glatiramer acetate.
Boziki M, Lagoudaki R, Melo P, Kanidou F, Bakirtzis C, Nikolaidis I, Grigoriadou E, Afrantou T, Tatsi T, Matsi S, Grigoriadis N. Boziki M, et al. Among authors: grigoriadou e. J Neurol Sci. 2019 Jun 15;401:43-50. doi: 10.1016/j.jns.2019.03.030. Epub 2019 Mar 29. J Neurol Sci. 2019. PMID: 31009931
Reduced expression of L-selectin in T-cells correlates with relative lymphocyte increase in patients with RRMS treated with natalizumab - functional implication towards PML risk.
Boziki MK, Karapanayotides T, Papadopoulos G, Lagoudaki R, Melo P, Bakirtzis C, Nikolaidis I, Gounari E, Tsavdaridou V, Skoura L, Afrantou T, Tatsi T, Grigoriadou E, Polyzoidou E, Mandoras N, Giantzi V, Kalogera-Fountzila A, Ioannidis P, Parissis D, Pelidou SH, Zoidou S, Grigoriadis N. Boziki MK, et al. Among authors: grigoriadou e. Neurol Res. 2020 Mar;42(3):209-221. doi: 10.1080/01616412.2020.1722913. Epub 2020 Feb 12. Neurol Res. 2020. PMID: 32048570
The Administrative Prevalence of Multiple Sclerosis in Greece on the Basis of a Nationwide Prescription Database.
Bakirtzis C, Grigoriadou E, Boziki MK, Kesidou E, Siafis S, Moysiadis T, Tsakona D, Thireos E, Nikolaidis I, Pourzitaki C, Kouvelas D, Papazisis G, Tsalikakis D, Grigoriadis N. Bakirtzis C, et al. Among authors: grigoriadou e. Front Neurol. 2020 Sep 29;11:1012. doi: 10.3389/fneur.2020.01012. eCollection 2020. Front Neurol. 2020. PMID: 33132996 Free PMC article.
COVID-19 Vaccination and Disease Course in People with Multiple Sclerosis in Greece.
Bakirtzis C, Konstantinidou N, Stavropoulou De Lorenzo S, Moysiadis T, Boziki MK, Grigoriadou E, Kesidou E, Theotokis P, Thireos E, Mitrou P, Grigoriadis N. Bakirtzis C, et al. Among authors: grigoriadou e. J Clin Med. 2023 Aug 23;12(17):5460. doi: 10.3390/jcm12175460. J Clin Med. 2023. PMID: 37685528 Free PMC article.
Effect of age and sex on craniomandibular disorders.
Koidis PT, Zarifi A, Grigoriadou E, Garefis P. Koidis PT, et al. Among authors: grigoriadou e. J Prosthet Dent. 1993 Jan;69(1):93-101. doi: 10.1016/0022-3913(93)90247-l. J Prosthet Dent. 1993. PMID: 8455176
Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy.
Katopodi T, Petanidis S, Grigoriadou E, Anestakis D, Charalampidis C, Chatziprodromidou I, Floros G, Eskitzis P, Zarogoulidis P, Koulouris C, Sevva C, Papadopoulos K, Roulia P, Mantalovas S, Dagher M, Karakousis AV, Varsamis N, Vlassopoulos K, Theodorou V, Mystakidou CM, Katsios NI, Farmakis K, Kosmidis C. Katopodi T, et al. Among authors: grigoriadou e. Pharmaceutics. 2024 Mar 25;16(4):455. doi: 10.3390/pharmaceutics16040455. Pharmaceutics. 2024. PMID: 38675116 Free PMC article. Review.
13 results